Medicine and Dentistry
Surface Enhanced Raman Spectroscopy
100%
Central Serous Retinopathy
50%
Spectral Domain Optical Coherence Tomography
49%
Breast Cancer
47%
Fluorescein Angiography
40%
Hemoglobin A1c
36%
Reproducibility
36%
Diabetes Mellitus
36%
Conjunctivitis
33%
Hyperglycemia
33%
Tooth Brushing
33%
Dentin
33%
LASIK
33%
Cancer Diagnosis
33%
Cataract Surgery
33%
Ranibizumab
33%
Balanced Salt Solution
33%
Glycation
33%
Cross-Link
33%
Photochemotherapy
33%
Aqueous Humor
33%
Helix
28%
Carboxamide
28%
Intraocular Lens
27%
Neoplasm
27%
Best Corrected Visual Acuity
26%
Optical Coherence Tomography
25%
Raman Spectrometry
25%
Visual Acuity
24%
Clinical Feature
22%
Photoreceptor Cell
21%
Keratitis
20%
Blood Glucose
20%
Nanomaterial
18%
Multiple Myeloma
18%
Controlled Release
18%
Epiretinal Membrane
18%
Disease
17%
Neurodegeneration
16%
Nitric Oxide
16%
Lovastatin
16%
Propylene Glycol
16%
Disease Exacerbation
16%
Glycemic Control
16%
Metastatic Carcinoma
16%
Adenoviridae
16%
Peripheral Corneal Relaxing Incision
16%
Corneal Ulcer
16%
Ulcerogenesis
16%
Macular Degeneration
16%
Pharmacology, Toxicology and Pharmaceutical Science
Ranibizumab
85%
Intravitreal Administration
54%
Carboxamide
53%
Adenoviridae
50%
Photodynamic Therapy
50%
Bevacizumab
35%
Growth Factor
33%
Cell Culture
33%
Hyperglycemia
33%
Central Serous Retinopathy
33%
Inflammation
23%
Vitreoretinopathy
21%
Vasculotropin
21%
Hemoglobin A1c
20%
Porous Silicon
19%
Leporidae
18%
Mevinolin
16%
Proliferative Diabetic Retinopathy
16%
Grape
16%
Pharmacodynamics
16%
Controlled Release
16%
Platelet Derived Growth Factor
16%
Microparticle
16%
Exudate
16%
Bortezomib
16%
Proanthocyanidin
16%
Rocuronium
16%
Prostaglandin E2
16%
Nitric Oxide
16%
Rapamycin
16%
Endophthalmitis
16%
Guanine
16%
Retrospective Study
16%
Retina Macula Hemorrhage
16%
Vasculotropin Antibody
16%
Wet Macular Degeneration
16%
Polypoidal Choroidal Vasculopathy
16%
Adenine
16%
Fluorescein
15%
Reactive Oxygen Metabolite
13%
Periodic Acid
13%
Disease
13%
Diabetic Retinopathy
12%
Matrigel
11%
Phenylalanine
10%
Biological Marker
10%
Age Related Macular Degeneration
10%
Combination Therapy
9%
Dobesilate Calcium
9%
Retina Neovascularization
9%